Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine-dexamethasone-honey mouthwash for symptom relief during radiotherapy in head and neck cancer
ChiCTR2400088302Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine, dexamethasone and Revamil in head and neck cancer (HNC) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Numeric Rating Scale pain score for the oropharynx during peri-radiotherapy. Started Aug 2024; status: recruiting.
02
Drugs
lidocainedexamethasoneRevamil
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on ChiCTR2400088302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088302.